Skip to content

New Feature: Text Message Treatment Updates

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated texts with the intention of collecting data on their medical cannabis treatment outcomes.

How It Works

When creating a new patient case, physicians input the patient’s phone number along with all other relevant information. Once a phone number is entered, a drop-down box will appear offering the physician to choose if the patient has opted in for text message updates. These text message updates will automatically be sent to the patient at a specific date and time with a request to rate their treatment efficacy on a scale of one (Adverse Reaction) to five (Total Resolution of Symptoms). All the patient will then have to do is respond with a number (1 through 5), and the data is collected in their case file.

The Benefit

“We want to ensure that physicians have real-time responses from their patients about their medical cannabis treatment plans,” said James West, founder and CEO of Arfinn Med. “Several states have long durations between required appointments, so physicians need to have tools to track their patients’ progress and create an open dialogue during a treatment period to increase the likelihood that the treatment plan will be further customized for the patient.”

Providing this type of feature will significantly save physicians time when collecting updates from patients. Instead of lengthy office visits or following up via phone call, one text can collect all the information needed. All data received through this text messaging feature is a real time update to help give a full picture of how that specific treatment is affecting each patient. Along with saving both the physician and patient time, this feature is also expected to increase patient retention. With such a hands-on approach, the text messaging feature will encourage patients to keep their physicians updated and refine the treatment plan, if/as needed, to obtain the results they desire.


At Arfinn Med, we are dedicated to helping medical professionals and their patients combat debilitating diseases and conditions with the use of medical marijuana. By relying on actual physician observations regarding patient outcomes, doctors can create reports based on the effectiveness, daily dosage and delivery mode of cannabis treatments specific to various patient demographics. Are you ready to join a nationwide network of medical professionals to learn more about medical marijuana and what it can do for your patients? Join Arfinn Med for FREE today!

Stories you may be interested in

Medical Marijuana Faces Acceptance Barrier by Hesitant Medical Schools

A new study shows a growing interest by university pharmacy programs in teaching about medical marijuana in their curriculum, while medical schools seem to lag behind. Sixty-two percent of U.S. pharmacy school respondents queried in a new survey said they included medical marijuana in their doctorate of pharmacy curriculum. That’s according to a nine-page study co-authored by…
Read More

Are You Prepared For Questions About Medical Cannabis?

With over 85% of Americans supporting legalizing medical cannabis, it’s inevitable that patients will begin asking their primary care doctors about its use and overall efficacy. Doctors and other medical professionals will be called upon to be ‘sense-makers’ for a treatment they never studied in medical school and have limited available research to draw upon. …
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

DeSantis OKs telehealth for Florida medical marijuana patients

TAMPA, Fla. (WFLA) — Florida Gov. Ron DeSantis signed a bill allowing the state’s 828,000 medical marijuana patients to use telehealth to visit their doctors. On Monday, DeSantis signed HB-387, titled “Medical Use of Marijuana,” which allows patients renewing their medical marijuana recommendation to meet with their doctors online. Currently, patients must visit their doctor in person…
Read More

Florida medical marijuana dispensary now sells the state’s first cannabis tablet

Even though Florida residents can finally smoke medical marijuana, one of the state’s largest cannabis companies is now offering it in tablet form. The company Curaleaf released the state’s first cannabis tablet on Sunday. The company’s two Orlando locations, at 775 N Semoran Blvd. and 12402 S Orange Blossom Trail, sell the mint-flavored tablets for $35 for a 30-quantity, child-resistant package. Read…
Read More

Medical marijuana advocates concerned over recreational cannabis proposals

ALBUQUERQUE, N.M.— Some medical marijuana patients are concerned the proposed framework for legalizing recreational marijuana could have a potentially negative impact on the medical cannabis program. “It’s something that will devastate the medical program in doing so,” said Jason Barker, a medical cannabis advocate with Safe Access New Mexico. A special task force delivered a…
Read More